[pending] VORICONAZOLE (VORICONAZOLE)
Pending LLM rewrite. Source: FDA_DRUG D-0319-2025.
- Product
- VORICONAZOLE — VORICONAZOLE (VORICONAZOLE)
- Category
- Drug
- Distribution
- Distributed nationwide
State
19,789 recalls have nationwide distribution and so reach Delaware. 0 additional recalls listed Delaware specifically in their distribution scope.
Most US product recalls have nationwide distribution — the manufacturer ships into every state and the recall sweeps the same way. We include those in this listing because they affect Delaware consumers even though the source notice doesn’t name the state. State-specific recalls are usually for products with regional distribution (a regional dairy, a local store brand) or where the agency was able to narrow the affected shipments to specific destinations.
If you’re checking whether a recall affects your purchase, the recall detail page lists the exact production lot codes, UPCs, and best-by dates. Match those against your package — distribution scope is a starting filter, not the final answer.
Pending LLM rewrite. Source: FDA_DRUG D-0319-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0359-2025.
Pending LLM rewrite. Source: FDA_FOOD F-0702-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0355-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-1549-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0312-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0326-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0322-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0315-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-1543-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0321-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0341-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0320-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-1530-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0346-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0331-2025.
Pending LLM rewrite. Source: FDA_FOOD F-0701-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0342-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0311-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0336-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0353-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0351-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0328-2025.
Glenmark Pharmaceuticals is recalling Lacosamide 150mg tablets nationwide due to manufacturing quality deviations. Consumers should contact their pharmacy or healthcare provider regarding their supply.
Glenmark Pharmaceuticals is recalling acetaminophen-ibuprofen tablets due to manufacturing quality deviations. No illnesses reported. Distributed nationwide via Amazon and Walmart.